Table 2 |
||||
|
Acute phase proteins in serum |
||||
|
eCRP |
fSAA |
gProcalcitonin |
||
|
dID |
mg/L |
mg/L |
μg/L |
|
|
|
||||
|
C01 |
<5 |
<11 |
0.06 |
|
|
C02 |
0.0 |
<11 |
0.05 |
|
|
C03 |
0.3 |
<11 |
0.10 |
|
|
C04 |
0.2 |
<11 |
0.06 |
|
|
C05 |
0.1 |
<11 |
0.07 |
|
|
C06 |
0.1 |
20 |
0.16 |
|
|
acontrol |
C07 |
0.2 |
<11 |
<0.05 |
|
C08 |
0.4 |
53 |
0.09 |
|
|
C09 |
1.9 |
<11 |
0.12 |
|
|
C10 |
1.0 |
14 |
0.06 |
|
|
C11 |
0.4 |
<11 |
<0.02 |
|
|
C12 |
3.5 |
28 |
0.06 |
|
|
C13 |
0.6 |
<11 |
0.09 |
|
|
C14 |
0.5 |
<11 |
0.06 |
|
|
|
||||
|
P01 |
<5 |
15 |
0.06 |
|
|
P02 |
3.3 |
13 |
0.04 |
|
|
P03 |
1.2 |
16 |
0.10 |
|
|
bafebrile |
P04 |
10.7 |
26 |
0.14 |
|
(AF) |
P05 |
1.0 |
<11 |
0.05 |
|
P06 |
0.5 |
<11 |
0.05 |
|
|
P07 |
3.3 |
59 |
0.03 |
|
|
P08 |
0.5 |
12 |
<0.05 |
|
|
|
||||
|
P05 |
>75 |
>600 |
0.21 |
|
|
P06 |
>75 |
560 |
0.12 |
|
|
P07 |
>75 |
560 |
0.08 |
|
|
cfebrile |
P08 |
44 |
>600 |
0.10 |
|
(F) |
P09 |
67 |
>600 |
0.14 |
|
P10 |
75 |
>600 |
0.10 |
|
|
P03 |
1.22 |
11 |
0.09 |
|
|
P04 |
>75 |
590 |
0.41 |
|
|
|
||||
|
Data shown as scatter plots in Additional File 2, Figure S1 a-dConcentration of acute phase proteins in sera from ahealthy children and PFAPA children in either an bafebrile interval or cwithin the first 20 hours of a febrile episode. Samples from FP03 and FP04 were drawn respectively ࿄ 12 hours before and ࿄120 hours after fever appeared. Numerical digits in the assigned didentification number (ID) are unique to individuals. Values in bold are outside the range for healthy children http://www.kliniskkemi.se webcite. eCRP; C reactive protein. Upper limit of detection is 75 mg/L. Concentration in healthy children is <5 mg/L. fSAA; serum amyloid A. Lower and upper limits of detection are 11 and 600 mg/L. Concentration in healthy children is <11 mg/L. gIn the absence of a bacterial infection, the concentration of procalcitonin is <0.2 μg/L. |
||||
|
Brown et al. BMC Pediatrics 2010 10:65 doi:10.1186/1471-2431-10-65 |
||||
